These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6520355)

  • 21. [Are the theoretical drawbacks of beta-blocker treatment in pregnancy being confirmed? A review of the literature].
    Tcherdakoff P; Goupil-Colliard M
    J Pharmacol; 1983; 14 Suppl 2():143-50. PubMed ID: 6138464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy.
    Lunell NO; Fredholm B; Hjemdahl P; Lewander R; Nisell H; Nylund L; Persson B; Sarby B; Wager J
    Acta Med Scand Suppl; 1982; 665():143-7. PubMed ID: 6961761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].
    Kharchenko VI; Savenkov PM; Romanova LV; Arkhipov SN; Borisova GG
    Sov Med; 1983; (9):84-8. PubMed ID: 6648691
    [No Abstract]   [Full Text] [Related]  

  • 27. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
    Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
    J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
    Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P; Pozet N; Sassard J; Vincent M
    Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of beta blockers (propranolol) in the treatment of arterial hypertension during pregnancy].
    Tcherdakoff P; Kreft C
    Acquis Med Recent; 1977; ():207-16. PubMed ID: 910599
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 33. Labetalol: the nineteen-eighties.
    Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):137S-141S. PubMed ID: 7093098
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    Plouin PF; Breart G; Maillard F; Papiernik E; Relier JP
    Br J Obstet Gynaecol; 1988 Sep; 95(9):868-76. PubMed ID: 3056503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Labetalol in the treatment of pregnancy arterial hypertension. 70 cases].
    Lardoux H; Blazquez G; Leperlier E; Chouty F; Gerard J
    Presse Med; 1986 Apr; 15(16):759-60. PubMed ID: 2941751
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current perspective of treating hypertension in pregnancy].
    Koucký M
    Vnitr Lek; 2011 Sep; 57(9):728-31. PubMed ID: 21957765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.